Arvinas (ARVN) Assets (2017 - 2026)
Arvinas (ARVN) recorded quarterly Assets of $647.5 million in Q1 2026, down 9.81% quarter-over-quarter from $717.9 million in Q4 2025, and down 35.32% on a YoY basis from $1.0 billion in Q1 2025.
Arvinas (ARVN) Assets (2017 - 2026) Analysis & Trends
Arvinas' Assets history runs 10 years deep, the most recent figure standing at $647.5 million for Q1 2026.
- In Q1 2026, Assets fell 35.32% year-over-year to $647.5 million; the TTM figure through Mar 2026 stood at $647.5 million (down 35.32% YoY), while the FY2025 annual figure was $717.9 million, down 34.22% from the prior year.
- Assets was $647.5 million for Q1 2026 at Arvinas, down from $717.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $1.5 billion in Q1 2022 to a low of $647.5 million in Q1 2026.
- Historically, Assets has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2026: Assets jumped 118.47% in 2022, then sank 35.32% in 2026.
- A 5-year view of Assets shows it stood at $1.3 billion in 2022, then gained by 2.82% to $1.3 billion in 2023, then dropped by 16.34% to $1.1 billion in 2024, then tumbled by 34.22% to $717.9 million in 2025, then decreased by 9.81% to $647.5 million in 2026.
- The last three Assets figures came in at $647.5 million (Q1 2026), $717.9 million (Q4 2025), and $844.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 647.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 647.50 Mn |
| Dec 31, 2025 | 717.90 Mn |
| Sep 30, 2025 | 844.30 Mn |
| Jun 30, 2025 | 909.30 Mn |
| Mar 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Sep 30, 2023 | 1.06 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.49 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Sep 30, 2021 | 1.60 Bn |
| Jun 30, 2021 | 644.03 Mn |